STARHEALTH Star Health and Allied Insurance Company Q4 FY26 results (Jan–Mar 2026) and concall
Star Health reported a strong FY26 with underwriting profit turning positive and normalized PAT growing 45% YoY, driven by strategic recalibration and improved operating levers. Despite a Q4 loss due to marked-to-market adjustments, the company emphasized its focus on quality of growth, customer experience, and digital transformation. Management remains confident in sustained high-teen growth and mid-teen ROEs, while addressing concerns around retail loss ratios and market share.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 13.9%, net profit up 11000.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 4,058 | 4,146 | 4,081 | 4,880 | 4,378 +8% | 4,566 +10% | 4,648 +14% |
| EBITDA | 147 | 285 | -7 | 588 | 75 −49% | 172 −40% | 148 +2214% |
| Net profit | 111 | 215 | 1 | 438 | 55 −50% | 128 −40% | 111 +11000% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
